Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours

Clinical Endocrinology

Volumn 45, Issue 2, 1996, Pages 195-200

  Pearce, S H S ^a   Trump, D ^a   Wooding, C ^a   Sheppard, M N ^b   Clayton, R N ^c   Thakker, R V ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENDOCRINE TUMOR; GENE DELETION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SUPPRESSOR GENE;

EID: 0029818901     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.d01-1561.x     Document Type: Article

References (32)

1. Arnold, A., Kim, H.G., Gaz, R.D., Eddy, R.L., Fukushima, Y., Byers, MG., Shows, T.B. & Kronenberg, H.M. (1989) Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. Journal of Clinical Investigation, 83, 2034-2040.
2. Arnold, A. (1993) Molecular genetics of parathyroid gland neoplasia, Journal of Clinical Endrocrinology Metabolism, 77, 1108-1112.
3. Barbareschi, M., Girlando, S., Mauri, F.A., Arrigoni, G., Laurino, L., Dalla-Palma, P., Doglioni, C. (1992) Tumour suppressor gene products, proliferation and differentiation markers in lung neuroendocrine neoplasms. Journal of Pathology, 166, 343-350.
4. Boggild, M.D., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., McTernan, P., Perrett, C.W., Thakker, R.V. & Clayton, R.N. (1994) Molecular genetic studies of sporadic pituitary tumours. Journal of Endocrinology and Metabolism, 78, 387-392.
5. Brown, A.C., Ross, P.M., Dunne, E.M., Steel, C.M. & WeirThompson, E.M. (1993) Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene, Nature Genetics, 3, 67-72.
6. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S. & Nordenskjold, M. (1990) Localisation of the MENI gene to a small region within chromosome 11q 13 by deletion mapping in tumours. Proceedings of the National Academy of Sciences, USA, 87, 1968-1972.
7. Cai, W.Y., Alexander, J.M., Hedley-Whyte, E.T., Scheithauer, B.W., Jameson, J.L., Zervas, N.T. & Klibanski, A. (1994) Ras mutations in human prolactinomas and pituitary carcinomas. Journal of Clinical Endocrinology and Metabolism, 78, 89-93.
8. Cryns, V.L., Alexander, J.M., Klibanski, A. & Arnold, A. (1993) The retinoblastoma gene in human pituitary tumours. Journal of Clinical Endocrinology and Metabolism, 77, 644-646.
9. Cryns, V.L., Thor, A., Xu, H.J. Hu, S.X., Wierman, M.E., Benedict, W.F. & Arnold, A. (1994) Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. New England Journal of Medicine, 330, 757-761.
10. Fearon, E.R. & Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
11. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P.. Marc, S., Bernardi, G., Lathrop, M. & Weissenbach, J. (1994) The 1993-4 Genethon human genetic linkage map. Nature Genetics, 7, 246-249.
12. Hardy, J. (1979) Transsphenoidal microsurgical treatment of pituitary tumours. In Recent advances in the Diagnosis and Treatment of Pituitary Tumours, (Ed. J.A. Linfool), pp. 375-388, Raven Press, New York.
13. Horowitz, J.M., Park, S.H., Bogenmann, E., Cheng, J.C., Yandell, D.W., Kaye, F.J.. Minna, J.D., Dryja, T.P. & Weinberg, R.A. (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proceedings of the National Academy of Sciences, USA, 87, 2775-2779.
14. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A. & Weinberg, R.A. (1992) Effects of an Rb mutation in the mouse. Nature, 359, 295-300.
15. Karga, H.J., Alexander, J.M., Hedley-Whyte, E.T., Klibanski, A. & Jameson, J.L. (1992) Ras mutations in human pituitary tumours. Journal of Clinical Endocrinology and Metabolism, 74, 914-919.
16. Knudson, A.G. (1971) Mutation and cancer: statistical study of retinoblastonia. Proceedings of the National Academy of Sciences. USA, 68, 820-823.
17. Lyons, J., Landis, C.A., Harsh, G., Vallar, L., Grunewakl, K., Feichtinger, H., Duh, Q.-Y., Clark, O.H., Kawasaki, E., Bourne, H. & McCormick, F. (1990) Two G protein oncogenes in human endocrine tumours. Science, 249, 655-659.
18. Melmed, S. (1994) Pituitary neoplasia. Multiple endocrine neoplasia. Endocrinology and Metabolism Clinics of North America, (Ed. R.F. Gagel) 23, 81-92.
19. Motokura, T., Bloom, T. Kim, H.G., Juppner, H., Ruderman, J.V., Kronenberg, H.M. & Arnold, A. (1991) A novel cyclin encoded by a be 11-linked candidate oncogene. Nature, 350, 512-515.
20. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., Benedict, W.F. & Prager, D. (1995) Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors. Evidence for a chromosome 13 tumour suppressor gene other than RB. Cancer Research, 55, 1613-1616.
21. Schantz, A. & Castleman, B. (1973) Parathyroid carcinoma: a study of 70 cases. Cancer, 31, 600-605.
22. Scheinman, S.J., Pook, M.A., Wooding, C., Pang, J.T.. Frymoyer, P.A. &Thakker, R.V. (1993) Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. Journal of Clinical Investigation, 91, 2351-2357.
23. Spada, A., Arosio, M., Bochicchio, D., Bazzoni, N., Vallar, L., Bassetti, M. & Faglia G. (1990) Clinical, biochemical, and morphological correlates in patients hearing growth hormonesecreting pituitary adenomas with and without constitutively active adenyl cyclase. Journal of Clinical Endrocrinology and Metabolism, 71, 1421-1426.
24. Thakker, R.V., Bouloux, P., Wooding, C., Chotai, K., Broad, P.M., Spurr, N.K., Besser, G.M. & O'Riordan, J.L.H. (1989) Association of parathyroid tumours in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. New England Journal of Medicine, 321, 218-224.13.
25. Thakker, R.V. (1993) The molecular genetics of the multiple endocrine neoplasia syndromes. Clinical Endocrinology, 38, 1-14.
26. Thakker, R.V., Pook, M.A., Wooding, C., Boscaro, M., Scanarini, M. & Clayton, R.N. (1993) Association of somatotrophinomus with loss of alleles on chromosome 11 and with gsp mutations. Journal of Clinical Investigation, 91, 2815-2821.
27. Thakker, R.V. (1995) Multiple endocrine neoplasia type 1 (MEN1). In Endrocrinology (Eds. L.J. DeGroot, G.M. Besser, H.C. Burger, et al.) pp. 2815-2831 W.B. Saunders, Philadelphia.
28. Weinberg, R.A. (1991) Tumor suppressor genes Science, 254, 1138-1145.
29. Woloschak, M., Roberts, J.L. & Post, K.D. (1994) Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer, 74, 693-969.
30. Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y.. Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D.. Fields, P. Marshall, G., Narod, S., Lenoir, G.M., Lynch, H., Feunteun, J., Devilee, Cornilisse, C.J., Menko, F.H., Daly, P.A., Ormiston, W., McManus, R., Pye, C., Lewis, C.M., Canon-Albright, L.A., Peto, J., Ponder, B.A.J., Skolnick, M.H.. Easton, D.F., Goldgar, D.E. & Stratton, M.R. (1994) Localization of a breast cancer susceptibility gene, BRCA2 to chromosome 13q12 13, Science, 265, 2088-2090.
31. Yandell, D.W. & Dryja, T.P. (1989) Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. American Journal of Human Genetics, 45, 547-555.
32. Zhu, J., Leon, S.P., Beggs, A.H., Busque, L., Gillitand, D.G. & Black, P.M. (1994) Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. Journal of Clinical Endocrinology and Metabolism, 78, 922-927.